Risk Profile Improvements

  • Material Weakness (improved) — Company remediated one of three prior material weaknesses (GAAP application controls that caused restatements) but still reports ineffective controls due to lack of documentation and segregation of duties.
NASDAQ: SSII SS Innovations International, Inc. 10-K

SSII doubles revenue to $42.5M, files FDA 510(k), raises $18.6M; installed base triples to 168 systems

Filed March 10, 2026 · Period ending December 31, 2025 · Compared to 10-K Apr 15, 2025 · ~2 min read

5 material changes detected in this filing.

Create a free account to read the full summary — it takes 30 seconds.

Partner

Trade SSII commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.